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Sertraline  (SRT)  is  a  widely  used  antidepressant  whose  poor  solubility  in water  limits  its  oral  applicability.
Thus,  the  aim  of  this  work  was  the  evaluation  of  a multi-equilibrium  system  based  on  -cyclodextrin
(CD)  and  SRT.  The  inclusion  compounds  (ICs)  were  investigated  by  infrared  spectroscopy,  isothermal
titration  calorimetry  (ITC)  and 1H  and  2D  ROESY  nuclear  magnetic  resonance  experiments.  SRT solubility
was  predicted  in  vitro  in  water  and  biomimetic  ﬂuids.  The  SRT  in  presence  of CD  at  1:1  and  1:2  molar
ratios  was  more  soluble  than  free  SRT in  all biomimetics  media  investigated.  The  FTIR-HATR  showed  that
CD  C–O–C  stretching  band  was  reduced  in  presence  of  SRT,  suggesting  the interactions  between  them.-Cyclodextrin
nclusion compound
heoretical calculations
hysical–chemical parameters
ulti-equilibrium
Additionally,  titration  process  and  Job’s  plot  provided  information  on  the  ICs  stoichiometry  and  evidenced
the  multi-equilibrium  coexistence  in  aqueous  solution.  According  to  the  ITC,  SRT:CD  interaction  process
was  spontaneous  and  exothermic  with  a  high  afﬁnity  binding  constant  (K =  14,726  M−1).  Additionally,  the
stoichiometry  coefﬁcient  (n) was  1.63,  which  was  comparable  to that  found  by FITR-HATR.  The 1H and
2D  ROESY  veriﬁed  multiple  SRT  sites  included  into  the  host  cavity.  Theoretical  calculations  depicted  the
relative  energy  of  different  proposed  ICs  structures,  in which  the  1:2  IC was  the  most  stable.. Introduction
Sertraline hydrochloride (SRT), Fig. 1a, is a selective serotonin
euptake inhibitor used for treatment of several disorders such
s depression, obsessive–compulsive, social phobia, panic, anxiety
nd eating issues. SRT is also the second most potent serotonin
euptake inhibitor and one of the top ten pharmaceutical products
old worldwide (Nouws et al., 2005). It is known that SRT presents
rawbacks, namely slow oral absorption, lower oral bioavailability
ue to its low solubility (3.8 mg  mL−1) (Johnson et al., 1996). Solu-
ility is a fundamental parameter in screening for drug absorption
ffective in the clinical response for almost all drugs given orally.
ral activity is obtained by dissolution of the drug and its bioavail-
bility depends on the drug behavior in the gastrointestinal tract
Hörter and Dressman, 2001). Studies have shown that more than
0% of drugs failures are due to poor bioavailability, which is a
onsequence of either low solubility or permeability or even both
Panchagnula and Thomas, 2000).
∗ Corresponding author. Tel.: +55 31 3409 5778; fax: +55 31 3409 5700.
E-mail  address: sinisterra@ufmg.br (R.D. Sinisterra).
378-5173 © 2011 Elsevier B.V.  
oi:10.1016/j.ijpharm.2011.09.026
Open access under the Elsevier OA license.© 2011 Elsevier B.V. 
Based on the biopharmaceutical drug classiﬁcation, SRT belongs
to Class II, i.e. low solubility and high permeability (Sutton et al.,
2006). To circumvent these drawbacks and to increase drug aque-
ous solubility, cyclodextrins (CDs) have been used as an efﬁcacious
strategy for several systems (Brewster and Loftsson, 2007; Davis
and Brewster, 2004). Although CDs have been applied in different
areas of science as biomaterials and drug delivery systems (Davis
and Brewster, 2004; De Sousa et al., 2010b; Harada et al., 2011), the
pharmaceutical interest in these molecules have arisen based on
their ability to modify chemical, physical and biological properties
of the guest molecules through inclusion compound (IC) formation
(De Sousa et al., 2010a; Marques et al., 2011; Uekama et al., 1998).
Additionally, CDs are able to improve solubility, stability and con-
sequently the bioavailability of the guest drug inserted into their
cavities (Loftsson and Duchene, 2007).
CDs molecules are composed mainly of 6, 7 or 8 glucopyranose
linked by -(1,4) glucosidic units, named -, -, -cyclodextrin,
respectively.  CDs have a torus shape, Fig. 1b, providing a hydropho-
bic cavity, while the hydroxyl groups located outside present a
Open access under the Elsevier OA license.hydrophilic character to this part of the molecule (Szejtli, 1998).
This feature allows CDs to form ICs, trapping a variety of guest
molecules into their cavity (Szejtli, 1998; Uekama et al., 1998). It has
been reported in the literature the coexistence of multiple inclusion
J.J. Passos et al. / International Journal of Pharmaceutics 421 (2011) 24– 33 25
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sents the most favorable IC stoichiometry in solution (de AraujoFig. 1. (a) Sertraline molecular str
odes of the guest molecules into the CD cavity in aqueous solution
De Sousa et al., 2008b; Messner et al., 2010). In this sense, a careful
hysical–chemical characterization concerning the supramolecu-
ar complex stoichiometry, binding sites and three-dimensional
rrangement can provide highly important information, helping to
hoose the best drug:CD ratio, which might lead to a better drug
ctivity.
Herein, we report the ICs characterization formed between SRT
ith CD at 1:1 and 1:2 molar ratios prepared by freeze-drying
FD) method in order to improve the guest molecule solubility in
queous medium. The supramolecular system ratio was  chosen
ased on the SRT possible binding sites with the CD molecule. To
tudy the changes in the SRT solubility after its interactions with
CD, equilibrium solubility experiments were carried out. SRT:CD
as investigated using different physical–chemical approaches in
queous solution to get insights about the supramolecular complex
rrangement, stoichiometry and binding constant.
. Materials and methods
.1.  Materials
Sertraline hydrochloride monohydrated was kindly given by
edley Pharmaceutical CO. S/A. -cyclodextrin (CD) was acquired
rom CERESTAR, USA.
.2.  Preparation of SRT:ˇCD inclusion compound by freeze drying
FD)
The  ICs were prepared mixing SRT and CD aqueous solutions
t 1:1 or 1:2 molar ratios. The SRT was added into the CD aque-
us solution and the ﬁnal solution was kept under stirring for 4 h
t room temperature. Then, the ICs solutions were frozen in liq-
id nitrogen and freeze-dried in a Thermo Electron Co. Equipment,
avant ModulyD. In order to verify the inﬂuence of the prepara-
ion process on the SRT solubility, free SRT aqueous solution was
ubmitted to FD process.
.3.  Equilibrium solubility (shake-ﬂask method)
Equilibrium solubility study of free SRT and ICs was carried
ut at 37 ◦C in the following dissolution media: water, simulated
astric ﬂuid (SGF) and simulated intestinal ﬂuid (SIF). The SGF
edium is HCl/KCl (0.05 mol  L−1) acid buffer solution at pH 2.0,
hile SIF is a phosphate buffer solution (0.05 mol  L−1) at pH 7.5
nd both media were prepared in absence of enzyme. Excess
f SRT or ICs were added into Eppendorf® tubes with 1.5 mL  of
issolution medium. These aqueous suspensions were shaken at
0 rpm at 37 ◦C for 48 h until solid/liquid equilibrium had been and (b) CD schematic structure.
achieved  (Baka et al., 2008). The suspension was  centrifuged at
12,000 rpm and ﬁltered with a 0.22 m Millipore® membrane ﬁl-
ters. SRT concentration in the ﬁltrate was  determined at  274 nm
using an UV–vis HP 8453 spectrophotometer using quartz cuvette
with 1.0 cm optical path. These UV–vis method used to quantify
the SRT was linear in the range of 0.08–0.40 mg mL−1, in accor-
dance with the calibration curves (see ﬁgures in Supplementary
Data 1), with linear ﬁtting values “r” higher than 0.99. The limit
of detection (LOD) was determined by spectrometric analysis at
 274 nm of 10 blank samples measurements, which was spiked
with low concentration of SRT (0.010 mg  mL−1). LOD values were
0.0006, 0.0010 and 0.0009 mg  mL−1 for water, KCl/HCl and PBS,
respectively. Limit of quantiﬁcation (LOQ) were 0.0019, 0.0033
and 0.0030 mg  mL−1 in water, KCl/HCl and PBS. The experiments
were carried out for free SRT and SRT submitted to the FD process
(SRTFD), as well as to the SRT:CD ICs obtained by this method at
1:1 and 1:2 molar ratios. These experiments were carried out in
triplicate.
2.4. FTIR-HATR measurements
FTIR-HATR  spectra of the CD, SRT and titration of CD in SRT in
aqueous solution were obtained using a Perkin Elmer spectropho-
tometer model, Spectrum GX equipped with reﬂection accessory
in a ZnSe crystal. All spectra were recorded between 4000 and
400 cm−1 with 4 cm−1 and 32 scans per measurement. After data
acquisition, all spectra were subtracted from MilliQ® water spec-
trum to reduce the water bands stretching inﬂuences. The ICs
stoichiometry was predicted by titration and continuous varia-
tion method (Job’s plot). In both methods, the stoichiometry was
estimated using the CD C–O–C stretching band at 1031 cm−1 in
presence and absence of SRT (De Sousa et al., 2008c).
In the titration process, CD aqueous solution at 12.0 mmol  L−1
was  titrated with SRT aqueous solution at 5.0 mmol  L−1 and the ﬁnal
concentration of both molecules varied from 1.1 to 6.0 mmol L−1
and 4.5 to 2.5 mmol  L−1, respectively. The difference of CD C–O–C
stretching at 1031 cm−1 (C–O–C) in the presence and absence
of SRT were plotted versus molar ratio ([CD]/[SRT]).
In addition, the stoichiometry was investigated by Job’s plot.
This method involves the mixture of equimolar aqueous solutions
keeping total molar concentration constant, however, the molar
fractions ([CD]/[CD] + [SRT]) varied from 0 to 1.0. According to
the continuous variation method, the maximum value observed
in the Job’s plot (C–O–C against [CD]/[CD] + [SRT]) repre-et al., 2007). Therefore, CD aqueous solution at 10.0 mmol L−1
was  mixed with different volumes of SRT solution aqueous at
10.0 mmol  L−1, in which molar fraction varied from 0.1 to 0.9. The
experiments were carried out at room temperature in triplicate.
26 J.J.  Passos et al. / International Journal of Pharmaceutics 421 (2011) 24– 33
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NFig. 2. SRT/CD inclusion modes
.5. Isothermal titration calorimetry (ITC)
SRT:CD thermodynamic parameters of interaction were iden-
iﬁed using a NanoITC 2G TA Instruments at 25 ◦C by measuring
he reaction heat ﬂow released. Each titration was carried out
s 50 successive injections of 5 L of CD aqueous solution at
4.0 mmol  L−1 into the reaction calorimetric cell, which contained
.2 mL  of SRT aqueous solution at 1.0 mmol  L−1. The ﬁrst injection
f 1 L was discarded to eliminate diffusion effects of the syringe
aterial into the calorimetric cell. The interval of 600 s was used,
hich was sufﬁcient to achieve equilibrium and signal return to
aseline and stirring in the calorimetric cell was kept constant
50 rpm. The reference calorimeter cell was loaded with 1.2 mL  of
illiQ® water and kept closed during the experiments. SRT and
CD concentration into the calorimetric cell varied from 1.0 to
.79 mmol  L−1 and 0.0 to 2.9 mmol  L−1, respectively. The dilution
rocesses were carried out of CD aqueous solution into pure water
nd pure water into the SRT aqueous solution, which were used
o subtracted from the SRT:CD titration curve. The calorimetric
ata were assay by NanoAnalyze software supplied with equip-
ent and the standard enthalpic variation (Ho), stoichiometry
n) and binding constant (K) obtained using the independent model
rom software. The standard Gibbs free energy (Go) and standard
ntropy variation (TSo) were calculated from titration data.
.6.  Nuclear magnetic resonance (NMR)NMR is powerful tool to study drug:CD interactions, allowing to
eﬁne the sites of interaction between host and guest molecules.
MR spectra were obtained in a Bruker DPX-400 AVANCEated by theoretical calculations.
operating at 400 MHz, using D2O (Cambridge isotopic 99.9%) as sol-
vent at 27 ◦C. One-dimensional 1H NMR  experiment was performed
with 5 mm dual probe using direct detection with z-gradient
coil and WATERGATE technique for suppression of the resid-
ual water signal. The 2D ROESY experiment was  recorder using
the inversion-recovery sequence (90-t-180). The standard exper-
imental parameters of the spectrometer library was  applied with
mixing time of 600 ms. The concentration of free SRT solution was
2.0 mg  mL−1, due to low solubility. All ICs solutions were taken in
the match concentration of free SRT solution. The water signal was
used to reference (Gottlieb et al., 1997).
2.7. Theoretical calculations
Starting  structure for the CD was obtained by the X-ray
structure deposited as code BCDEXD10 ((CSD):http://www.ccdc.
cam.ac.uk/)  at the Cambridge Structural Database available for CD
hydrated (Lindner and Saenger, 1982). The water molecules present
in this crystal structure were excluded for all calculations follow-
ing the same procedure from our previous works (De Sousa et al.,
2008a). SRT crystal structure was also used as the initial geometry
(Caruso et al., 1999). The isolated molecules were fully optimized
at DFT (Burke et al., 1988) level using the PBE1PBE (Perdew et al.,
1996, 1997) functional with the Pople’s standard split valence 6-
31G(d,p) basis set (Hehre et al., 1972). Vibrational analysis was also
performed for the characterization of the optimized structures as
true minima on the potential energy surface (PES).
SRT structure has two planar phenyl rings (A and B) in its
molecular structure that are closely orthogonal to each other
and connected by an unsaturated ring (C). This ring is in a chair
nal of Pharmaceutics 421 (2011) 24– 33 27
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onformation and it is also bonded to the methyl ammonium chlo-
ide structure as showed in Fig. 1a. The SRT chemical arrangement
ith the narrower and wider rims of CD, and also the two differ-
nt stoichiometries investigated provide 16 possible geometrically
istinct ICs as can be seen in Fig. 2. For the designed supramolec-
lar ICs, the geometry optimizations were ﬁrst carried out at the
M3 (Stewart, 1989) level semiempirical level. For the PM3  most
table ICs geometry optimizations were carried out at the DFT
evel with the PBE1PBE (Perdew et al., 1996, 1997) functional
sing the 6-31G(d,p) (Ditchﬁeld et al., 1971) basis set followed
y harmonic frequency calculations, which has a high computa-
ional cost, specially for the 1:2 IC stoichiometry. The solvent effect
as taken into account following the integral equation formal-
sm polarized continuum model (IEFPCM) (Cances et al., 1997).
his method describes the condensed phase as a classical elec-
ronic medium represented by the solvent dielectric constant (for
ater ε = 78.39). The solute molecule is placed in a suitable cavity
o enclose the entire molecule. The solute cavities for all struc-
ures were described by the Universal Force Field (UFF) atomic
adii. All theoretical calculations were carried out using Gaus-
ian 2003 (Frisch et al., 2004) suite of computational chemistry
rograms.
. Results and discussion
.1.  Equilibrium solubility shake ﬂask method
In a broad sense, solubility may  be deﬁned as the amount of
ubstance that dissolves in a given volume of solvent at a speci-
ed temperature. The SRT molecule is poorly soluble in water, and
ccording to literature, its solubility depends on pH of the medium
Johnson et al., 1996). In order to quantify the SRT solubility after its
nteraction with CD, equilibrium solubility of ICs were measured
n gastrointestinal biomimic ﬂuids and water. Thus, to determine
he equilibrium solubility of free SRT, SRTFD and SRT in the ICs at
:1 and 1:2 molar ratios were carried out.
Free SRT solubility in water is 4.0 ± 0.23 mg  mL−1 in accordance
o reported in the literature, which is 3.80 mg  mL−1 (Johnson et al.,
996). SRT solubility in the ICs at 1:1 and 1:2 molar ratios using
ater as solvent were 25.60 ± 0.75 and 32.0 ± 0.60 mg  mL−1, which
epresents a solubility increases of six and eight times higher than
RT, respectively. These SRT increased solubility in presence of
CD is an evidence of the interaction between both molecules in
queous solution. However, water solubility does not represent the
astrointestinal tract conditions, mainly pH medium. Thus, to sim-
late these conditions, SRT solubility was measured in SGF and SIF
iomimetic ﬂuids, which is given at speciﬁc buffered pH (Hörter
nd Dressman, 2001). It is clear that the SRT, in presence of CD,
as more soluble than free SRT under those tested conditions. SRT
olubility of at 1:1 and 1:2 molar ratios in SGF medium are 5.0 ± 0.93
nd 12.80 ± 0.65 mg  mL−1, respectively, which were higher than
ree SRT in the same solvent (1.5 ± 0.05 mg  mL−1). These results
howed that SRT solubility enhanced after CD interaction using
iomimetic gastric ﬂuid.
Although free SRT and SRT in presence of CD present lower
olubility in SIF medium compared to water and SGF media, SRT
olubility values at 1:1 and 1:2 molar ratios in SIF medium are
.80 ± 0.10 and 1.0 ± 0.37 mg  mL−1, while the free SRT solubility
s 0.3 ± 0.03 mg  mL−1. The low solubility of SRT in SIF medium may
e due to the increase of the pH, where the predominant species
n solution is the SRT non ionized form. The SRT is weak acid (pKa
.16) and is soluble in low pH solutions due to the protonated sec-
ndary amino group, on the other hand, increasing the pH medium
avors the SRT non protonated form, which is less soluble (Takács-
ovák et al., 2006). However, comparing the SRT solubility of freeFig. 3. FTIR-HATR of spectra of free SRT (3.3 mmol L−1), CD (3.3 mmol L−1) and
SRT:CD  IC at 1:1 molar ratio in the region of 1600–800 cm−1.
molecule and its ICs at 1:1 and 1:2 molar ratios it was  observed
enhancement of 166 and 233%in SIF medium, respectively.
In  order to study the inﬂuence of the FD process in drug solubil-
ity, SRT solubility was  also investigated in the absence of CD after
this process, SRTFD. SRTFD solubility values in water, SGF and SIF
dissolution media are 5.6 ± 0.21, 1.8 ± 0.16 and 0.6 ± 0.03 mg  mL−1,
respectively. It is clear that the FD process increases the SRT solu-
bility in range from 20, 25 and 100% in water, SGF and SIF medium,
when compared to free SRT in the same media. This increase in
the SRTFD solubility may  be due to changes in molecular features
of the sample, such as crystallinity, porosity and polymorphism
(Baka et al., 2008). However, the increase in SRT solubility after
interaction with CD was more pronounced than observed after
FD process, demonstrating the interaction between host and guest
molecules.
According to solubility deﬁnitions and provisional biopharma-
ceutical classiﬁcation reported in the literature, SRT is classiﬁed
at slightly soluble compound, which range from 1 to 10 mg  mL−1
(Sutton et al., 2006). SRT solubility at 1:1 molar ratio is
25.6 ± 0.76 mg  mL−1, which changes of the molecule solubility clas-
siﬁcation from slightly soluble to sparingly soluble (range from 10
to 33 mg  mL−1). Furthermore, the solubility of SRT at 1:2 molar ratio
is 33.2 ± 0.60 mg  mL−1, which can be classiﬁed as soluble (range
from 33 to 100 mg  mL−1), according the literature. Finally, analyz-
ing these results, SRT:CD system at 1:2 molar ratio has proved
to have a higher solubility than 1:1 IC in all solvents evaluated,
suggesting that increasing the CD molar ratio can favor the SRT
solubility.
3.2. FTIR-HATR measurements
FTIR-HATR  has been applied to host-guest spectroscopy eval-
uation, allowing the characterization of system in solid state
(Cannavà et al., 2008). However, spectroscopic technique has been
recently used to demonstrate the host-guest interaction between
drug:CD complex in aqueous solution. Additionally, stoichiometry
of drug:CD complex in solution can be achieved using two methods:
titration and continuous variation method (Job’s Plot) (De Sousa
et al., 2008b).
SRT  and CD FTIR-HATR spectra in aqueous solutions were mon-
itored in the range of 1600–800 cm−1 to prevent the OH stretching
−1bands interference. SRT spectrum at 3.3 mmol  L aqueous solu-
tion did not present any detectable bands around 1600–800 cm−1,
according to Fig. 3. The absence of SRT bands at this wavenumber
may be due to the low SRT concentration in bulk solution. On  the
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ontrary, free CD aqueous solution at 3.3 mmol  L−1 presents the
haracteristic C–O–C stretching band at 1031 cm−1, Fig. 3. When
omparing the vibrational modes at 1031 cm−1 of the CD in pres-
nce and absence of SRT in an equimolar ratio, it was observed
 strong intensity reduction of the C–O–C stretching, Fig. 3. This
esult can be attributed to the exchange of water molecules inside
f CD cavity for the guest molecule, which can restrict -(1–4)
C–O–C vibrational freedom. This observation is in accordance with
revious one observed by De Sousa and coworkers, which is an
vidence of the interaction between drug and CD (De Sousa et al.,
008a).
FTIR-HATR spectrum of CD during the titration process in
ater was monitored in a range of 1600–800 cm−1. Dependence
etween C–O–C stretching at 1031 cm−1 and the CD concentra-
ion was observed (see ﬁgure in Supplementary Data 2). However,
hen CD aqueous solution was titrated in SRT aqueous solution
t 5.0 mmol  L−1, an intensity decrease of the C–O–C stretching
and was veriﬁed (see ﬁgure in Supplementary Data 3). These
esults can be better summarized in titration plot of CD with
RT aqueous solution, which depicts the C–O–C stretching at
031 cm−1 against molar ratio ([CD]/[SRT]), Fig. 4a. This titra-
ion was adjusted to a nonlinear ﬁtting. This nonlinear proﬁle
ould be attributed to the host-guest weak interactions, observed
n supramolecular systems, which are derived from the different
nteractions between host and guest molecules. Additionally, an
nﬂection point around 1.56 is observed, suggesting that an equi-
ibrium between different supramolecular systems can be observed
n solution. In order to estimate the IC stoichiometry, the continu-
us variation method was carried out and the result is showed in
ig. 4b.
Fig. 4b presents a maximum molar fraction around 0.60
ndicating that supramolecular species with molar ratio stoi-
hiometry higher than 1:1 can be favored in solution among
ther supramolecular arrangements. However, coexistence of less
avored stoichiometries should not be discarded, since titration
ethod presents a factionary molar ratio. FTIR-HATR methods
rovided evidences about the SRT and CD interactions, demon-
trating the coexistence of different stoichiometries in solution.
owever, the FTIR-HATR technique is not the most precise tool to
dentify the supramolecular system stoichiometry based on weak
ntermolecular forces involving CDs. In order to evaluate the ther-
odynamic parameters of the SRT:CD IC system, calorimetric
easurements were carried out by ITC.
.3. Isothermal titration calorimetry (ITC)
The interaction of host and guest molecules results in an
nthalpy change, which can be detected by ITC. The interac-
ion process can be exothermic or endothermic, according to the
upramolecular system afﬁnity (Sun et al., 2006a). The heat ﬂow
f CD titration into the SRT solution is shown in Fig. 5a. The heat
ow proﬁle indicates that SRT:CD interaction process is exother-
ic, since heat ﬂow increases during the titration process. The heat
utput after each injection of CD was determined by integrating
ach peak versus time, and plotting the data against the molar ratio.
he heat ﬂow of the CD and SRT dilution process in water did not
resent enthalpy variation, Fig. 5b.
Based on these experiments, standard enthalpy change (Ho),
quilibrium constant (Ki) and stoichiometry coefﬁcient (n) were
btained by NanoAnalyze® software, applying independent model
tting. The standard Gibbs free energy change (Go) and entropy
offect (TS ) was derived according to Eqs. (1) and (2), respectively.
Go = −RT ln Ki (1)
Go = Ho − TSo (2) Pharmaceutics 421 (2011) 24– 33
ITC stoichiometry coefﬁcient value (n = 1.62) obtained by indepen-
dent model ﬁtting is close to the stoichiometry coefﬁcient estimated
using FTIR-HATR titration method (n = 1.56). This result obtained by
ITC reinforces the FTIT-HATR capacity to identify the supramolecu-
lar system stoichiometry in solution. Moreover, ITC n value suggests
that a higher supramolecular system than 1:1 molar ratio in solu-
tion must be consider as a stable IC.
The experimentally determined Ho is −8.7 kJ mol−1 and repre-
sents the energy released during IC formation, Fig. 5c. The negative
enthalpy value could be attributed to guest interaction with CD
through the weak supramolecular forces, such as van der Waals,
hydrophobic interaction, hydrogen bond and electrostatic interac-
tions (Sun et al., 2006b). These interactions were reported in other
supramolecular host-guest systems and in general it is associated to
the aromatic ring insertion into the CD cavity (Bouchemal, 2008).
Furthermore, the IC formation could be aided to entropy con-
tribution (TSo). The entropy change during the IC formation was
evaluated having a positive value, −TSo = −15.10 kJ mol−1, Fig. 5c.
The positive entropy effect may  be due to entropy compensation,
which is a result of the negative contribution of host-guest inter-
actions (conformational restriction) and the positive contribution
of the water molecules release from the CD cavity (Rekharsky
and Inoue, 1998). Usually, hydrophobic interactions are governed
by entropy, this occurs when enthalpy contributions is lower than
entropy effect according to |Ho| < |TSo|. On the other hand, van
der Waals interactions forces is enthalpy driven and could be or not
aided by entropy, |Ho| > |TSo| (Bouchemal, 2008). Thus, when
compared to lower enthalpy variation Ho |8.7 kJ mol−1|and higher
entropy contribution TSo |15.10 kJ mol−1| can be concluded that
SRT:CD complexation was  driven by entropy and aided by
hydrophobic interactions, Fig. 5c. The positive entropy effect shows
more greatly contributes to negative standard Gibbs free energy
Go compared to the heat effect. The standard Gibbs free energy
is negative Go = −23.80 kJ mol−1 indicating that SRT:CD interac-
tion in aqueous solution is spontaneous, Fig. 5c.
Additionally, a high binding constant formation value was
observed, Ki = 14,726 M−1, suggesting the large afﬁnity between
SRT and CD. Thus, negative Go and high Ki value conﬁrm
that SRT:CD interacts in aqueous solution. Despite the fact that
the calorimetry experiments indicate the type of interactions in
host-guest system, it is not possible through the thermodynamics
parameters deﬁne the interaction binding sites of the supramolec-
ular system, which can be determined through NMR  experiments.
3.4.  Nuclear magnetic resonance (NMR)
NMR spectroscopy has been used to establish inclusion geom-
etry and ICs stoichiometry. Guest molecule included into the CD
cavity can change the dipolar moment of both molecules, leading
to a hydrogen chemical shift. These results can be used as probe
of host-guest interaction. Fig. 6 shows the 1H NMR  spectra of SRT
dissolved in D2O in absence and presence of CD and Table 1 sum-
marizes the chemical shifts values of the host and guest hydrogens.
The ıH values observed for free CD are in agreement with those
reported in the literature (Schneider et al., 1998). 1H NMR spectrum
of free SRT in D2O, Fig. 6a, shows all SRT hydrogens: the aliphatic
ones H1′, H2′, H3′, H4′ and H17 and those aromatic, which can be
better depicted in Fig. 6b. Hydrogens H8, H15 and H6′, H7, H12
of the aromatic region are overlapped, however, it is important to
emphasize that H5′and H16 are bonded in aromatic rings A and C,
respectively.
Fig. 6c and d present the 1H NMR  spectra of the SRT:CD IC at 1:1
molar ratio. It can be observed a chemical shift change (ı)  for all
hydrogen in the IC spectrum compared to the free SRT spectrum. A
higher variation in the NMR  ı  was  observed for the SRT aromatic
hydrogens in presence of CD, Fig. 6d. The ı for host and guest
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olecules are presented in Table 1. SRT ı  values of the H5′and
16 aromatic hydrogens are, respectively −0.114 and 0.094 ppm
nd this variation suggests that the SRT interaction with CD can
ccur with two different guest molecule sites. Comparing H2′and
′3 ı  values of IC and free SRT aliphatic hydrogens the ı  was
.137 and 0.156 ppm. These results suggest that aliphatic hydro-
ens were affected by changing the chemical environment around
RT molecule. On the other hand, aliphatic hydrogens H1′, H4′ and
ig. 5. ITC titration of SRT solution 1.0 mmol L−1 with CD solution 14.0 mmol L−1 at 25 ◦C
©), CD aqueous solution in water () and SRT in CD () (subtracted from blank exp
ntropic change values (in units of kJ mol−1). L−1) obtained using transmittance values at 1031 cm−1 and (b) continuous variation
H17 were less affected than H2′and H3′ in presence of CD. The
aromatic hydrogen H8, H15, H6′, H7 and H12 were overlapped and
the ı  of chemical shift were not calculated.
One of the best probes to study drug:CD interactions is the ı
of the H3 and H5 located inside the CD cavity, as depicted Fig. 1b
(Fernandes et al., 2003). Chemical shift change in of the hydrogens
H3 and H5 suggest the partial or entire insertion of drug in the CD
cavity (Schneider et al., 1998). IC ı  in values of the H3 and H5
: (a) heat ﬂow (W) versus time, (b) titrations curves water in SRT aqueous solution
eriments), (c) standard Gibbs free energy, standard enthalpy change and standard
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Fig. 6. 1H NMR spectra in D2O (400 MHz) of (a) free SRT, (b) expansion of free SRT from ı
to 7.60.
Table 1
1H NMR  chemical shifts (ppm) of free SRT, CD and SRT:CD IC at 1:1 molar ratio
at  27.0 ◦C (400 MHz, in D2O).
1H chemical shift /ppm
*H H IC** ı
SRT
H1′ 4.490 4.561 0.071
H2′ 2.150 2.287 0.137
H3′ 1.896 2.052 0.156
H4′ 4.168 4.104 −0.064
H5′ 6.934 6.820 −0.114
H8; H15 7.498–7.431 7.566–7.444 n.c.
H6;H7;H12 7.383–7.261 7.443–7.352 n.c.
H16 7.117 7.211 0.094
H17 2.774 2.828 0.054
-CD
H1 5.030 5.016 −0.014
H2 3.610 3.634 0.024
H3 3.930 3.660 −0.257
H4 3.550 3.566 0.016
H5 3.840 3.585 −0.255
H6 3.800 3.842 0.042
n.c., ı  not calculated.
a
i
c
m
a
c
tem at 1:1 and 1:2 molar ratio, in accordance with FTIR-HATR* Free SRT and -CD hydrogens.
** IC-SRT:-CD IC at 1:1molar ratio prepared by FD.
re, respectively −0.257 and −0.255 ppm, while H6 located at rim
s less affected and presents the ı  0.042 ppm. The results obtained
omparing the ı  values indicated the interaction between both
olecules in solution. The host–guest system formed to drug:CD
re driven by weak intermolecular forces and ı  of H3 and H5
ould be explained by replacement of high energy water molecules 6.70 to 7.60, (c) SRT:CD IC at 1:1 molar ratio and (d) expansion of IC from ı 6.70
inside  the cavity by the guest molecule and the change in electronic
density upon the inclusion process (Denadai et al., 2007; Sun et al.,
2006a). However, 1H NMR  spectrum is not the best tool to study
spatial interaction between the hydrogens in host–guest system.
In  this sense, Nuclear Overhauser Effect (NOE) has been exten-
sively used to study IC spatial correlations in short distance. The 2D
rotating frame NOE (ROESY) is a powerful method to study spatial
relationship in host–guest systems whose hydrogens are coupled
in short distances, smaller than 5 A˚ (Jullian et al., 2008). 1H/1H 2D
ROESY contour map  of SRT:CD IC at 1:1 molar ratio in D2O and
the expansion contour map  for the aliphatic and aromatic region of
SRT are depicted in Fig. 7a–c, respectively. Fig. 7a shows the contour
map and cross peak correlations between CD internal hydrogens
(H3; H5) and aliphatic and aromatic SRT hydrogens. These cross
peaks correlation of SRT aliphatic can be seen in the expansion
contour map, in Fig. 7b. The cross peak correlation of the internal
CD hydrogens (H3; H5) occur with those SRT aliphatic hydrogens
H2′ and H17, however, hydrogens H1′, H3′, and H4′ do not present
dipolar cross peaks correlation with CD hydrogens.
Another 2D ROESY expansion contour map  of SRT aromatic
hydrogens is presented in Fig. 7c. An intense cross peaks between
H5′and H16 aromatic hydrogens of SRT was  observed with H3 and
H5 CD internal hydrogens. Once H5′and H16 aromatic hydro-
gens are bonded in aromatic rings A and B, respectively, these
cross peaks suggest that CD interacts with two  SRT molecu-
lar sites. This result suggests the existence of SRT:CD ICs with
1:2 stoichiometry and/or existence of an multi-equilibrium sys-and ITC experiments. However, even using a powerful NMR  tech-
nique (2D ROESY), which demonstrated the binding sites between
host and guest molecules a precisely information concerning the
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upramolecular structure could not be achieved. To predict the
ost favorable supramolecular complex structure theoretical cal-
ulations were done to SRT:CD ICs at different molar ratios and
ssuming a variety of spatial arrangements.
.5. Theoretical calculations
A  theoretical investigation at a molecular level is an addi-
ional and complementary tool to elucidate the structure of the
Cs. Over the past few years, we have been working jointly
sing experimental and calculated data to deﬁne the geometry of
hese supramolecular arrangements (De Sousa et al., 2008b). The
xperimental results enable us to rationalize the stoichiometry
elationship between the host and guest molecules, and also the
ost preferred inclusion modes and theoretical calculations allow
s to evaluate the speciﬁc sites of interactions upon inclusion. In
articular, these antidepressant molecules have as the key factor
or their activity the distance between the center of the aromatic
ing and the basic nitrogen atom that could be affected by the CDs
nvironment (Chang et al., 1993; Dalpiaz et al., 1996).
Following the PM3  energetic data presented in Table 2, one
an see that among all 1:1 SRT/CD calculated structures, the IC
V (Fig. 2) is the most stable, and is quite close to second most
table complex VIII, with the relative energy difference between
hem being 2.3 kJ mol−1. These two complexes are related to the
nclusion of the aliphatic group, when the interaction is toward the
arger and smaller rim of CD, respectively. This energetic simi-
arity is also noticed for the pairs of complexes: VII and III, when
oth phenyl and unsaturated rings (A and B, Fig. 1a) are enclosed
y the CD cavity. Complex VII, which relates that narrower rim
nclusion, is 5.0 kJ mol−1 more stable than the wider one. When the
nalysis refers to all the complexes modeled, one can infer that 1:2
RT/CD X is the most stable complex. This stabilization is noticed
ue to the ﬁtting of the SRT molecule inside both CD cavities,
lso allowing closer interactions between the primary hydroxyls
roups. Some C–H· · ·O hydrogen bonds that frequently occur in car-
ohydrates and can inﬂuence the conformation of the host-guestexpansion of the aliphatic region ı 3.20–5.20 and ı 6.60–7.60 and (c) expansion of
selectivity  are also present in this complex between the CDs uni-
ties, as well as, with the aliphatic methyl and the primary OHs.
The energetic variation within the 1:2 complexes is more drastic
than that observed in the 1:1 set. This may  be due to the different
kind of intermolecular interactions deﬁned in the 1:2 complexes
that include the CD–CD contacts. Complex II is the most unstable
calculated structure (E  = 87.2 kJ mol−1), and probably this is a
result of a shallow inclusion of the dichlorophenyl ring regardless
of the high potential for an inclusion trough the CD larger rim. The
superﬁcial interaction is also the reason for the complex XIV to be
the least stable among the 1:2 set. All PM3 optimized ICs are rep-
resented in the supporting material (see ﬁgure in Supplementary
Data 4).
The  structure of the three most stable complexes, X, IV and VIII,
were reoptimized at the DFT level, using the reasonable 6-31G(d,p)
basis set. For these DFT optimized complexes we also performed
a vibrational analysis at the same theoretical level, which requires
a large amount of computer time. The ﬁnal geometries, which are
true local minima, having no imaginary frequencies, are presented
in Fig. 8. There are no drastic differences in the structures when
comparing to the PM3  results, however, the thermodynamics has
some variations without changing the relative stabilization order.
These parameters are shown in Tables 2 and 3. For the DFT results,
the distinction between the larger rim and smaller rim inclusion
at 1:1 stoichiometry is more pronounced, with the wider inclusion
(complex IV), being 35.6 kJ mol−1 more stable than the narrower
one in complex VIII. Comparing complex IV with complex X, the
1:2 arrangement is still the most stable, however, the DFT  energy
difference is just 7.6 kJ mol−1, which indicate a major equilibrium
of these two  species.
It  is important to mention that water plays an important role in
the complexes stabilization, and the implicit solvent model (PCM),
in spite of its robustness, does not include the important water
molecules that are inside the CD cavity. Since, these results are
calculated by the relative difference between products and reac-
tants, we expect that error should be cancelled out. Keeping this in
mind, complex X is still the most stable of the set, and the implicit
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Table  2
Calculated thermodynamic data of the inclusion complex formation according to the equation: nCD + SRT → nCD· · ·SRT in gas phase at PM3  level and T = 298.15 K.
Inclusion complex E(kJ mol−1) E(kJ mol−1) G(kJ mol−1) H(kJ mol−1) −TS(kJ mol−1)
1:1 SRT:CD
I −41.5 71.2 41.5 −34.4 75.9
II  −25.4 87.2 31.6 −19.8 51.4
III  −53.3 59.3 24.6 −46.7 71.3
IV  −68.7 43.9 30.2 −59.2 89.4
V  −50.1 62.5 45.6 −41.3 86.9
VI −42.6  70.1 41.0 −34.2 75.2
VII −58.3  54.4 30.8 −50.5 81.3
VIII  −66.4 46.3 28.5 −56.1 84.6
1:2  SRT:CD
IX  −89.7 22.9 154.8 −67.8 222.6
X  −112.6 0 83.3 −96.9 180.3
XI −72.7  39.9 156.4 −57.9 214.2
XII −86.5 26.2 133.9 −68.8 202.7
XIII  −69.1 43.6 95.1 −58.7 153.8
XIV  −65.7 46.9 85.6 −54.9 140.5
XV  −84.3 28.4 80.6 −72.6 153.3
XVI −77.4 35.2 93.5 −63.3 156.8
Table 3
Calculated thermodynamic data of the inclusion complex formation according to the equation: nCD + SRT → nCD· · ·SRT. Results for complexes X, IV and VIII at DFT/6-
31G(d,p) level and T = 298.15 K.
ICs E(kJ mol−1) E(kJ mol−1 G(kJ mol−1 H(kJ mol−1 −TS(kJ mol−1 Esol(kJ mol−1
1:1 SRT:CD
IV  −53.0 7.6 8.5 −38.7 47.3 –
VIII  −17.4 43.2 34.7 −11.0 45.8 –
1:2 SRT
X  −60.6 0 80.8 
Fig. 8. Optimized PBE1PBE/6-31G(d,p) geometries for the most stable ICs at 1:1
SRT/CD (a), IV (b) VIII and at 1:2 SRT/CD (c) X./CD
−41.0 121.8 –
solvation yields an additional stabilization of 102.1 kJ mol−1 to the
electronic plus nuclear–nuclear repulsion energy value, if com-
pared to the one in gas phase.
It  is clear that the enthalpy variation shows an exothermic
process, as well as, recognized by ITC results. The enthalpic con-
tribution involves the formation or destruction of intermolecular
interactions. Interestingly, the enthalpy variation on the IC forma-
tion is quite similar between some 1:1 and 1:2 compounds. In this
case, as mentioned before, the lack of a more sophisticated sol-
vent model is not a big problem due to the error cancellation. In
spite of this, the calculated entropic contribution shows quite a
different magnitude as well as sign, which is mostly due to the
absence degree of freedom of the explicit water molecules in the
model. In the experimental procedure, both SRT and CD were
highly hydrated, previous to the IC formation, and there were highly
ordered water molecules around both molecules. Upon inclusion,
the solvation shells are individually reorganized favoring the G
of the supramolecular complex. The most stable complexes pre-
dicted by the theoretical calculations are in structural agreement
with the experimental data, suggesting an 1:1 and 1:2 equilibrium,
especially for complex X that shows a complete inclusion of SRT by
two  CDs simultaneously, enclosing both phenyl rings and also the
aliphatic chain.
4.  Conclusions
In this work the IC between SRT and CD were obtained and the
system was  characterized by different methods. The results of these
techniques suggest that this supramolecular system presents a 1:1
and 1:2 SRT:CD stoichiometries in equilibrium simultaneously in
aqueous solutions. The IC obtained was more soluble than free SRT
in different biomimetic ﬂuids and this solubility enhances when
CD molar ratio increases. SRT:CD interaction was conﬁrmed by
the CD C–O–C stretching modes reduction, allowing to estimate
nal of
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he IC stoichiometry in solution. ITC experiments demonstrated
hat SRT and CD inclusion process is exothermic and sponta-
eous, accompanied by high afﬁnity binding constant. IC formation
as driven by entropy and the hydrophobic interaction between
he SRT and CD was predominant. The stoichiometry coefﬁcient
etermined by ITC experiments is supported by FTIR-HATR titra-
ion and Job’s plot. 1H NMR  experiments evidenced the SRT and
CD interactions based on the hydrogens chemical shift. Moreover,
D ROESY contour maps showed mainly cross peaks correlations
etween SRT aromatic hydrogens and the internal CD hydrogens.
heoretical calculations were useful to elucidate the most energet-
cally stable structures among the multiple inclusion possibilities.
rom these results, one can infer that the 1:2 inclusion is the most
table, but do not discard equilibrium with 1:1 complexes as well
s observed in experimental data.
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